Literature DB >> 6848401

Diagnostic efficacy of hepatic computed tomography in the detection of body iron overload.

J M Howard, C N Ghent, L S Carey, P R Flanagan, L S Valberg.   

Abstract

To determine whether or not hepatic computed tomography density is an alternative to liver biopsy for the diagnosis of body iron overload, hepatic computed tomography density was determined in healthy controls, patients with idiopathic hemochromatosis, and patients with liver disease. Hepatic computed tomography density was obtained from a single computed tomography slice taken through the liver on a General Electric CT/T 8800 scanner. In 69 controls, hepatic computed tomography density ranged from 11 to 36 units (mean = 30). Given an upper limit of normal of 36 computed tomography units, 4 of 6 untreated patients with idiopathic hemochromatosis had elevated hepatic computed tomography density compared with 0 of 8 patients after venesection (X2 = 7.5, p = 0.01). Hepatic computed tomography density correlated directly with serum ferritin (r = 0.72, p = 0.01). In 58 consecutive patients with clinical or biochemical evidence, or both, of liver disease who underwent liver biopsy for diagnostic purposes, 0 of 52 patients with normal hepatic iron had an elevated hepatic computed tomography density as compared with 4 of 6 patients with excess iron (X2 = 35, p less than 0.001). An elevated hepatic computed tomography density associated with an elevated serum ferritin indicates iron overload; however, a normal hepatic computed tomography density does not exclude iron overload. When computerized tomography is applied to patients with an unexplained elevation of the serum ferritin, it provides a noninvasive alternative to liver biopsy for the detection of excess hepatocellular iron.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6848401

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

1.  Computed tomography in nonalcoholic fatty liver disease: a useful tool for hepatosteatosis assessment?

Authors:  Deniz Güney Duman; Cigdem Celikel; Davut Tüney; Nese Imeryüz; Erol Avsar; Nurdan Tözün
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

Review 2.  Magnetic resonance imaging measurement of iron overload.

Authors:  John C Wood
Journal:  Curr Opin Hematol       Date:  2007-05       Impact factor: 3.284

3.  Hepatic iron overload: diagnosis and quantification by noninvasive imaging.

Authors:  J L Chezmar; R C Nelson; J A Malko; M E Bernardino
Journal:  Gastrointest Radiol       Date:  1990

4.  Diagnosis of Systemic Diseases Using Infrared Spectroscopy: Detection of Iron Overload in Plasma-Preliminary Study.

Authors:  Leonardo Barbosa Leal; Marcelo Saito Nogueira; Jandinay Gonzaga Alexandre Mageski; Thiago Pereira Martini; Valério Garrone Barauna; Leonardo Dos Santos; Luis Felipe das Chagas E Silva de Carvalho
Journal:  Biol Trace Elem Res       Date:  2021-01-07       Impact factor: 3.738

Review 5.  Assessing the Non-tumorous Liver: Implications for Patient Management and Surgical Therapy.

Authors:  Pallavi Pandey; Ankur Pandey; Mary Dillhoff; Carl Schmidt; Ihab R Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-09-18       Impact factor: 3.452

Review 6.  Iron overload cardiomyopathy: better understanding of an increasing disorder.

Authors:  Pradeep Gujja; Douglas R Rosing; Dorothy J Tripodi; Yukitaka Shizukuda
Journal:  J Am Coll Cardiol       Date:  2010-09-21       Impact factor: 24.094

7.  Experimental study of iron effect on the liver function.

Authors:  M Hasegawa; H Takenaka; A Shinotsuka
Journal:  Ann Nucl Med       Date:  1988-05       Impact factor: 2.668

8.  MRI of hepatic iron deposition in patients with renal transplant.

Authors:  F H Miller; M R Fisher; W Soper; R M Gore
Journal:  Gastrointest Radiol       Date:  1991

9.  Hypoparathyroidism and subclinical hypothyroidism with secondary hemochromatosis.

Authors:  Hyung Ki Jeong; Joon Hwan An; Hyoung Sang Kim; Eun Ae Cho; Min Gui Han; Jung Sik Moon; Hee Kyung Kim; Ho-Cheol Kang
Journal:  Endocrinol Metab (Seoul)       Date:  2014-03-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.